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Abstract
Fusobacterium necrophorum is a rare causative agent of otitis and sinusitis. Most commonly known is the classic Lemierre’s syndrome of
postanginal sepsis with suppurative thrombophlebitis of the jugular vein. We report five patients diagnosed recently with a complicated
infection with F. necrophorum originating from otitis or sinusitis. Two patients recovered completely, one patient died due to complications
of the infection, one patient retained a slight hemiparesis and one patient had permanent hearing loss. Diagnosis and management are
discussed. A possible factor in the emergence of F. necrophorum is proposed.
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Introduction
Fusobacterium necrophorum is an anaerobic, non-spore forming
pleomorphic Gram-negative rod which is considered a
commensal of the animal and human upper respiratory,
gastro-intestinal and female genital tract. It can cause a variety
of human infections, but is most commonly known as the
main cause of postanginal sepsis with suppurative
thrombophlebitis of the jugular vein (Lemierre’s syndrome).
Less well known is the otogenic variant with mastoiditis and
intracranial complications such as meningitis, abscesses and
sinus thrombosis [1]. We report five patients with a recent
diagnosis of complicated infection with F. necrophorum
originating from otitis or sinusitis with significant morbidity
and mortality.
Case 1
A 9-year-old healthy girl, presented to the emergency
department with fever, headache and vomiting. Two weeks
before presentation the general practitioner had diagnosed an
acute otitis media which was treated with co-amoxiclav for 7
days. The fever persisted intermittently with otalgia. One day
before admission she developed otorrhoea and vomiting. On
admission she was acutely ill with a temperature of 39.6°C,
purulent discharge of the right ear, postauricular tenderness
and nuchal rigidity. Cerebral spinal fluid revealed neutrophilic
pleocytosis (2399/lL). Empiric antibiotic treatment was
started with ceftazidime. A computed tomography scan of
the brain showed total obliteration of the right mastoid,
thrombosis of the sigmoid sinus and epidural empyema of
8 mm in the posterior surface of the temporal bone. Gram
staining of the middle ear fluid showed pleomorphic
Gram-negative rods, suggestive for the presence of Haemo-
philus influenzae. Gram staining of the cerebrospinal fluid did
not reveal any bacteria. Shortly after admission an urgent
mastoidectomy was performed. Post-operatively the patient
did not regain consciousness (Glasgow Coma Scale
E1M1Vtube) and there were no pupillary light reflexes. The
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cultures after 1 day were negative. Antibiotic therapy was
switched to meropenem. Repeated computed tomography of
the brain revealed massive cerebral oedema with brainstem
herniation. There was a progressive loss of all brainstem
reflexes despite maximal therapy and treatment was with-
drawn. The patient died 24 h after admission. Autopsy of the
brain showed cerebral oedema with herniation, thrombosis of
the sigmoid sinus and the transverse sinus and there was
purulent discharge mainly in the posterior cranial fossa. The
cultures taken during life (middle ear fluid and mastoid) and
from the autopsy revealed F. necrophorum, identified by
matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry (MALDI-TOF MS; Microflex, Bruker Daltonik,
Bremen, Germany).
Case 2
A previously healthy, 9-year-old girl presented to the
emergency department with the suspicion of meningitis. Nine
days before admission she started with topical treatment
(dexamethasone–framycetin–gramicidin eardrops, Sofradex;
Sanofi-aventis Netherlands B.V., Gouda, the Netherlands) for
otitis and otorrhoea. Five days before admission she developed
high fever, headache and vomiting and, consecutively, neck pain
and stiffness 2 days before admission. She appeared acutely ill,
but was fully conscious. Cerebrospinal fluid examination
revealed a marked neutrophilic pleocytosis (1 280 000/lL).
Empiric antibiotic therapy was started with ceftazidime. When
pleomorphic Gram-negative rods were seen in the Gram
staining of the cerebrospinal fluid, the antibiotic therapy was
switched to meropenem. Computed tomography of the brain
showed mastoiditis with thrombosis of the sigmoid sinus and a
small empyema. An urgent mastoidectomy was performed.
Post-operatively the patient was admitted to the intensive care
department. Fusobacterium necrophorum was cultured after
24 h from the cerebrospinal fluid, and identified by MAL-
DI-TOF MS. Antibiotic therapy was changed to penicillin.
Magnetic resonance imaging (MRI) showed an additional
right-sided pontine infarct. She recovered slowly and after
4 days she was transferred to the paediatric ward. The
penicillin was continued for 18 days and then switched to
clindamycin for another 3 weeks. The patient experienced no
diarrhoeal problems during the use of clindamycin. Tinzaparin
was started for the sinus thrombosis and continued for
3 months. After 20 days of hospitalization she was discharged,
at that moment she experienced urinary and faecal inconti-
nence and a hemiparesis of the left leg. Six months later the
urinary and faecal incontinence had recovered, there was still a
very mild hemiparesis of the left leg.
Case 3
A 2-year-old boy presented at the Ear, Nose and Throat Clinic
with fever, otorrhoea and mastoiditis. Six weeks prior to
admission he underwent adenoidectomy and received tymp-
anostomy tubes in another hospital. Post-operatively he was
re-admitted with fever and otitis for which he received several
antibiotic treatments including amoxicillin, co-amoxiclav and
ceftazidime. One week after discharge his symptoms returned.
On admission his temperature was 39°C. Since 2 days he had
had otorrhoea and mastoiditis was suspected. A computed
tomography scan of the mastoid showed a Bezold’s abscess
with partial thrombosis of the sigmoid sinus and the right vena
jugularis. A cortical mastoidectomy was performed with
drainage of the abscess. On admission co-amoxiclav and
ceftazidime were given. Gram stains of fluid from the right ear
and the right mastoid showed slender, small Gram-negative
rods. Anaerobic cultures revealed F. necrophorum (shown by
using MALDI-TOF MS). No aerobic growth was observed. F.
necrophorum was also cultured from the Bezold’s abscess.
Blood culture remained negative. Antibiotic treatment was
changed to penicillin. The patient showed good clinical
improvement. After 2 weeks he was discharged with clinda-
mycin for 1 month. The patient experienced no diarrhoeal
problems during the use of clindamycin.
Case 4
A 42-year-old man with a suspicion of mastoiditis and
meningitis was transferred from another hospital to the
intensive care unit of our hospital. His symptoms, right ear
pain and a sore throat, started a few days before his first
admission. One day before admission the patient showed an
altered mental status, lateralization and lowered level of
consciousness. On presentation he was febrile with tachycar-
dia, a lowered level of consciousness, left muscle weakness and
right ear discharge, possibly liquorrhoea. A computed tomog-
raphy scan of the brain showed otitis and mastoiditis with total
obliteration of the right mastoid, subdural empyema, two
intraparenchymal abscesses in the right frontal and temporal
lobe and a midline shift to the left. No sinus thrombosis was
present. Right middle ear cultures were taken and amoxicillin,
ceftriaxone and metronidazole were administered. Cultures
revealed F. necrophorum (identified by Vitek 2; bioMerieux,
Marcy l’Etoile, France). Amoxicillin was discontinued. Blood
cultures remained negative. A hemicraniectomy was per-
formed to drain the subdural empyema. Subsequently, a loss of
sensitivity of his right ear and temporal skin was observed
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along with a conductive hearing loss. Fourteen days after the
operation an MRI scan of the brain showed a fronto-temporal
abscess on the right side, increase in subdural effusion on the
left side and midline shift to the right. He underwent surgery
and antibiotic therapy was changed to meropenem and
vancomycin. The patient improved. After 10 days the
vancomycin was stopped and he was transferred back to the
other hospital in good clinical condition with meropenem.
After 8 days the patient was discharged. Antibiotic therapy
was continued for 3 months according to the decision of the
clinician. He experienced permanent hearing loss of the right
ear.
Case 5
A 14-year-old boy was admitted to the neurosurgical ward
with ethmoiditis and meningeal irritation. Over the course of
several days he had developed a headache, fever 38.5°C, a
swollen left eye, vomiting, malaise and dizziness. He had no
history of sinusitis. On admission he had a temperature of
39°C, meningeal irritation, a red pharynx, a swollen left eyelid
which he was unable to open and a red left conjunctiva. An
MRI scan showed an abscess in the paranasal sinus with
obliteration of the left orbita and intracerebral frontal
involvement with dural enhancement. A blood culture and
a nasal swab were taken for culture and empiric antibiotic
treatment was started with ceftriaxone and metronidazole.
The next day the anaerobic blood culture bottle turned
positive with slender pleomorphic Gram-negative rods which
were also seen in the Gram stain of the nasal swab.
Fusobacterium necrophorum (MALDI-TOF MS) was cultured
from the blood and nasal swab. After 5 days the patient
became somnolent and a subsequent MRI scan of the brain
showed a progression of the abscess subcutaneously, left
intraorbital and intracranial along with progression of
subdural empyema and a suspected thrombosis of the
superior sagittal sinus and right sigmoid sinus. A craniotomy
was performed. The Gram stain of pus from the temporal
pocket showed Gram-negative rods, but cultures remained
negative. Ceftriaxone was changed to meropenem.
Post-operatively, the patient showed clinical improvement.
Four days later he showed increasing headache and a left
hemiparesis. Evacuation of right frontal subdural abscess was
performed. Meropenem was changed to penicillin. Six days
later an intraorbital abscess was evacuated. His left hemipa-
resis disappeared completely. A low protein S level was
found for which further analysis was initiated. Three weeks
later the patient was discharged in good condition with
penicillin for 1 month (Table 1).
Discussion
We report five patients with a diagnosis of complicated
infection with F. necrophorum originating from otitis or sinusitis
within a time period of 9 months. Only two patients
recovered completely, one patient died due to complications
of the infection, one patient retained a slight hemiparesis and
one patient had permanent hearing loss.
The first description of human systemic infection with F.
necrophorum was made by Veillon and Zuber in 1898 of a
young child with chronic purulent otitis media with septic
arthritis of the knee, cerebral abscess and signs of overwhelm-
ing systemic infection. Courmont and Cade made the first
description in 1900 of human postanginal septicaemic infection
with F. necrophorum. The disease was more clearly character-
ized by Lemierre in 1936, but it was not until 1983 that, for the
first time, the term Lemierre’s syndrome was used [1].
The most common presentation of Lemierre’s syndrome is
postanginal septicaemia with septic thrombophlebitis of the
internal jugular vein and distant septic metastases secondary to
an acute oropharyngeal infection. Fusobacterium necrophorum is
an unusual cause of mastoiditis, sinusitis and meningitis with a
limited number of published reports [2–10]. Fusobacterium
necrophorum can cause invasive disease with severe complica-
tions in previously healthy children and adults. Binding and
activation of plasminogen, platelet aggregation, and production
of haemagglutinin by F. necrophorum are all likely to be important
in the pathogenesis of abnormal coagulation and inflammation
seen in patients with Lemierre’s syndrome [1, 11]. This
corresponds with the high rate of thrombotic complications
observed in four of five patients in our analysis. In addition, some
strains appear to be more virulent due to binding of factor H, a
complement controlling glycoprotein [12].
Its uncommon presentation and the difficulties encountered
in isolating F. necrophorum, with the delay of adequate
treatment, contributes to the high morbidity and mortality.
In Case 1 appropriate antibiotics for F. necrophorum were
delayed for 12 h due to the initial suspicion of infection with
encapsulated H. influenzae. In cases of a severe course of an
acute otitis media or sinusitis, especially with thromboembolic
complications, abscess formation and pleomorphic Gram-neg-
ative rods in the Gram stain, the empiric antibiotic treatment
must include agents to treat F. necrophorum. Various antibiotics
are currently being used, as illustrated in our case series. No
uniform guidelines exist, though most authors recommend the
combination of penicillin and metronidazole or carbapenems
[1]. There are conflicting reports in the literature on the
susceptibility of Fusobacterium isolates to penicillin. Some older
studies report on beta-lactamase-producing strains of Fusobac-
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terium isolates [13, 14]. In a recent study, all F. necrophorum
isolates were susceptible to penicillin (MIC <0.5 mg/L) [15]. In
the Netherlands, resistance of Fusobacterium isolates to
penicillin is very rare and was not found in two previously
published cases of F. necrophorum infections in the Netherlands
[3, 10], nor in our case series.
Although F. necrophorum is considered to be a commensal of
the human upper respiratory tract, its role as a pathogen of
throat infection is also considered. Using real-time PCR, Jensen
[16] detected F. necrophorum in 48% of 61 throat swabs from
patients with non-streptococcal tonsillitis and in 21% of 92
throat swabs from healthy controls. Ludlam et al. [17] analysed
throat swabs from 411 university students and 103 patients
with a sore throat. A swab copy count of 50 000 or more was
significantly more frequent in the group of patients with a sore
throat (35%) compared with the asymptomatic subjects (4.6%).
Using conventional anaerobic culture techniques, two studies
in patients with sore throat report the presence of
F. necrophorum in 4.9% and 9.7%, respectively [18, 19].
Within a short time period (9 months), we encountered
five patients with a complicated infection with F. necrophorum
originating from otitis or sinusitis. Interestingly, two recent
studies from Israel also report on the emergence of F.
necrophorum infections associated with complicated mastoid-
itis. Yarden-Bilavsky et al. [20] describe seven children with
acute F. necrophorum mastoiditis diagnosed during a 3.5 year
period of whom five presented in the last 6 months of the
study. In a second study, 17 of 27 F. necrophorum infections in
children were diagnosed during the last 4 years of a 10 year
study period. The most common source of infection was
otogenic (70%) [21]. Three older surveys from Denmark
(1990–1995), Wisconsin (1995–2001) and France (1995–
2006) demonstrated a temporary increase in Lemierre’s
syndrome [22–24]. Most authors speculate that the more
restricted use of antibiotics and the shift in prescribed
antibiotics from traditional antibiotics such as penicillin to
macrolides and cephalosporines, which lack activity against F.
necrophorum, as well as improved identification methods by
the use of broad-spectrum 16S rRNA PCR have contributed
to this increase in incidence. However, the Netherlands is
known for having a restricted antibiotic prescription policy
for upper respiratory tract infections well before the
apparent increase of F. necrophorum infections, which has
not changed during the last few years. Although microbio-
logical laboratories in the Netherlands introduced MALDI--
TOF MS in 2009, resulting in a significant improvement in the
identification of anaerobes [25], it is unlikely that this
pathogen has been unrecognized in severe syndromes as
occurred in the patients we described when using
conventional identification techniques.
Another possible explanation could be the pneumococcal
vaccination, which was incorporated in the national
immunization programme in the Netherlands in 2006. The
nasopharynx of children is colonized by multiple microorgan-
isms. Numerous associations between these viral and bacterial
pathogens have been found during nasopharyngeal carriage
[26]. It is increasingly recognized that disruption of this
microbiota with its synergistic and interfering interactions
facilitates respiratory tract infections such as otitis media [27,
28]. Replacement of vaccine serotype pneumococci by
non-vaccine serotypes after pneumococcal vaccination and
its effects on carriage of and infection with other common
pathogens such as H. influenzae, Moraxella catarrhalis and
Staphylococcus aureus has been described in several studies [28,
29]. However, meta-genomic analyses have shown a high
variability of the nasopharyngeal microbiota, including the
presence of F. necrophorum and other less prevalent commen-
sals [30]. We hypothesize that an increase in F. necrophorum
infections may be explained by a similar disrupting impact of
pneumococcal vaccination.
In conclusion, we report five patients diagnosed recently
with complicated infection with F. necrophorum originating
from an otitis or sinusitis. Imaging should be considered in all
infections with Fusobacterium arising from the upper
respiratory tract or head region due to the high incidence of
thrombotic complications and abscess formation. Appropriate
antibiotics should not be delayed. The reason for the recent
emergence of F. necrophorum infections is not clearly
established.
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